Product Description:
Palbociclib is indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with:
- an aromatase inhibitor as initial endocrine based therapy in postmenopausal women.
- fulvestrant in women with disease progression following endocrine therapy.
Product Features:
| Product Name | : | Palbonix |
| Generic Name | : | Palbociclib |
| Formulation | : | Capsule |
| Available Pack Size | : | 21’s Pot |
| Available Strength | : | 125mg |
| Registrations | : | Export Only |
| Website | : | Palbonix.com |
